Dynamic, site-specific interaction of hypoxia-inducible factor-1α with the von Hippel-Lindau tumor suppressor protein

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4136-4142

  Yu, Fang ^a   White, Sarah B ^a   Zhao, Quan ^a   Lee, Frank S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VON HIPPEL LANDAU TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; COBALT THERAPY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL HYPOXIA; COBALT; COS CELLS; DNA-BINDING PROTEINS; FUNGAL PROTEINS; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; LIGASES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROTEINS; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0035872479     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. 2 homeostasis by hypoxia-inducible factor 1
2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
3. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
4. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α
5. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway
6. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
7. 2 tension
8. Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension
9. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit
10. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein
11. 2 homeostasis
12. 2 sensing
13. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
14. 2-dependent degradation domain via the ubiquitin-proteasome pathway
15. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
16. Substrate targeting in the ubiquitin system
17. The VHL tumour-suppressor gene paradigm
18. The elongin BC complex and the von Hippel-Lindau tumor suppressor protein
19. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
20. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
21. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
22. Identification of the von Hippel-Lindau tumor suppressor protein as part of an active E3 ubiquitin ligase complex
23. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
24. Inhibition of transcription elongation by the VHL tumor suppressor protein
25. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase
26. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2
27. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
28. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
29. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
30. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein
31. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein
32. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
33. An ATF/CREB binding site is required for virus induction of the human interferon β gene
34. Software and database for the analysis of mutations in the VHL gene
35. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor α (HIF-α) proteins
36. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit
37. Angiogenesis: How a tumor adapts to hypoxia
38. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
39. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1